Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia
- 14 November 2002
- journal article
- case report
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 30 (11) , 793-796
- https://doi.org/10.1038/sj.bmt.1703736
Abstract
A 17-year-old male with chronic myelogenous leukemia in blast crisis received a non-T cell-depleted (TCD) HLA haplo-identical three-loci mismatched hematopoietic stem cell transplant (HSCT) from his mother. Long-term feto-maternal microchimerism was detected by nested polymerase chain reaction with sequence-specific primer typing. The post-transplantation prophylaxis against graft-versus-host disease (GVHD) was tacrolimus with minidose methotrexate. Sustained engraftment was obtained. Acute GVHD (grade 2) developed, but improved rapidly. Bone marrow aspiration on day 120 showed complete remission. Non-TCD HLA haplo-identical HSCT based on feto-maternal microchimerism might be feasible and has important implications in the selection of alternative family donors in HSCT.Keywords
This publication has 8 references indexed in Scilit:
- Superior survival of blood and marrow stem cell recipients given maternal grafts over recipients given paternal graftsBone Marrow Transplantation, 2001
- LEC induces chemotaxis and adhesion by interacting with CCR1 and CCR8Blood, 2000
- Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantationBone Marrow Transplantation, 1999
- The Effect of Tolerance to Noninherited Maternal HLA Antigens on the Survival of Renal Transplants from Sibling DonorsNew England Journal of Medicine, 1998
- Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancyBlood, 1996
- Mismatches of Minor Histocompatibility Antigens between HLA-Identical Donors and Recipients and the Development of Graft-Versus-Host Disease after Bone Marrow TransplantationNew England Journal of Medicine, 1996
- Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic PhaseAnnals of Internal Medicine, 1988
- Marrow Transplantation from Related Donors Other Than HLA-Identical SiblingsNew England Journal of Medicine, 1985